Idorsia : Transforming the Horizons of Therapeutic Options

 

The medicinal industry has continued to evolve along with the simultaneous evolution of the human community. The treatment of different ailments was aided by various plants and herbal remedies that were discovered in the early days of medicine. Since then, the pharmaceutical space has gone through several changes that have made it the dynamic industry which it is today.

The pharmaceutical sector has evolved to become a multibillion-dollar industry. The long and complicated process of demonstrating a compound’s safety and efficacy in the laboratory has improved the success ratio of medicines. Pharmaceutical companies are constantly working on novel therapies that will help people live longer and healthier lives.

Pharmaceutical firms create, manufacture, sell and distribute these therapies on a daily basis all around the world. Many companies are giving their key contributions to the development of the pharmaceutical industry. One of the prominent names on that list is Idorsia Pharmaceuticals.

Exhibiting True Excellence

Idorsia is a high-potential biopharmaceutical firm based in Switzerland, Europe’s biotech heartland, that specializes in the discovery, development, and commercialization of new small molecules with the goal of changing the pharmaceutical landscapes.

Idorsia began its operations on June 15, 2017, following the demerger from Actelion, with registered shares of Idorsia Ltd being listed on the SIX Swiss Exchange the next day. Idorsia, while a start-up at heart and only 4.5-year-old on paper, this company starts hitting the ground running with a 20 year heritage of discovering and developing innovative therapies for patients in need.

Mission and the Strategy

Idorsia’s mission is to become a leading mid-sized biopharmaceutical company. The company’s key strengths are its full pipeline, established and well networked teams of drug discoverers, clinical developers, and commercialization specialists, housed in state-of-the-art laboratories and office spaces, supported by a strong balance sheet. Idorsia’s strategy is to harness these key strengths and use them to build a company that discovers, develops, and commercializes innovative drugs.

In order to fulfil its mission, Team Idorsia has formulated five-mid-term key strategic priorities to achieve long-term success:

Deliver at least three projects to market

Build a world-class commercial organization

Bring Idorsia to sustainable profitability

Fuel the pipelines with new discoveries

Utilize state of the art technologies

Now, it’s all about execution!

Inspiring Leadership

Jean Paul Clozel has been the Chief Executive Officer of Idorsia Pharmaceuticals Ltd. since 2017. He achieved his medical degree in France. Further, he completed the training in pharmacology and physiology at the University of Montreal, Canada, and at the University of California, San Francisco, US.

He is an experienced cardiologist and was Head of the Drug Discovery Group in the Cardiovascular Department of F. Hoffmann-La Roche. He is one of the founders of Actelion in 1997 and was its CEO for the period of 2000-2017. He also serves as a Member of the Board of Idorsia Ltd.

Read More.

eVisit: Simplifying Healthcare Delivery and Empowering Doctors

 

Miles Romney started his career in health-tech, building the first EHR for wireless, mobile devices in-clinic. He then moved heavily into security, architecting solutions for secure data transmission and storage to satisfy what were, in those days, the ‘new’ HIPAA requirements.

From there, Miles moved into entertainment, building packet-streaming encryption systems for secure video and audio broadcasting. He spent fifteen years in that industry: running an animation studio and pioneering ‘digiclay animation’; building a media company that ran online ops for some 1,500 newspapers and TV stations before they sold it; then running a tech-enabled film distributor. “I loved all that!” Miles Romney recounts.

“But I got to a point, running the film distributor, where I felt like I was one of many people talking a lot about the world’s problems without actually doing anything to solve them—I wanted to move the needle. Healthcare was my likely choice, given my background. And I peg the high cost and uneven availability of healthcare as the second-largest problem in the world,” he added.

He connected with Bret Larsen who had spent his career in telehealth, and who had a compelling thesis on what the industry was doing right, and what it was doing wrong. Bret sold Miles on that vision.

Together, they determined that telehealth was also the ‘wedge’ technology that would enable literally everything else because it decouples care from the point of care, and it introduces a tech intermediary between the patient and provider—an intermediary that can build over time to facilitate care in ever-evolving ways.

eVisit was born!

Miles Romney was appointed the CTO and Bret Larsen became the CEO of the ambitious and visionary organization—eVisit.

…and then, Cometh the Pandemic

The onset of COVID-19 in the United States in 2020, of course, was like knocking over a beehive; and telehealth was right in the thick of it. It was a busy year for eVisit (putting it mildly).

The eVisit team hit utilization 12 times that of their previous peak almost overnight. At one point, the company onboarded around seven thousand providers in a matter of ten days, and by year’s end, it grew its revenues by nearly 600%.

“We got into telehealth confident that an inflection would come. We didn’t know it would be a pandemic, we’re sorry it was,” said the CTO, regretfully. “But 2020 ended with America’s health systems in a considerably more prepared position for the next major challenge than they were a year before.”

“We deeply lament the challenges and loss of life imposed by COVID-19, but we believe in making lemonade out of lemons, and we’re pleased to have been a part of not only surviving the pandemic but also in leveraging its lessons to future preparation, for the future preservation of life and health,” he further added.

The very low impact COVID-19 has had on children, for example, sets it apart from all of history’s other major outbreaks, rising to the level of miraculous. The team at eVisit has had, alongside everyone working in healthcare, an opportunity to discover where their vulnerabilities lie so that they can be prepared for the next one—which may be much worse.

A part of that preparation is embracing remote-care workflows in the widespread deployment and adoption of hybrid care. This is where eVisit’s passion lies. Sure, eVisit can help patients and providers connect for the isolated cold and flu—and it does that. But the real power of its platform lies in holistic care and wellness, connecting every episode of care to a patient’s lifelong health.

And this is what the healthcare industry has to get good at in order to efficiently and effectively service a billions-large global population in an uncertain future.

Read More:

Hope Care: Bringing Healthcare to Your Home

 

The leading telehealth solution providers around the world exhibit their excellence in remote delivery of healthcare services. They provide evaluation, diagnosis, and evaluation facilities to patients without any in-person visit.

These companies enable patients to communicate from their homes by using internet and other technologies – providing lasting treatment experiences to the patients.

One such established telehealth solutions provider is Hope Care. It is one of the first national companies in the digital health arena to combine services, technological platforms, and products, allowing the provision of a totally innovative social and health care service.

By promoting the well-being of its clients wherever they are, Hope Care collects and monitors vital signs at a distance and provides digital health service through advanced technologies. The company primes for the development of m-Health concepts together with support services.

At the helm of Hope Care’s ceaseless success is its Founder, Jose Paulo Carvalho. His vision came from a personal experience when his mother was diagnosed with amyotrophic lateral sclerosis (ALS) in early 2003. Mr. Carvalho states that the lesson learned from this experience has 3 key points:

– His mother wanted to live independently, so the challenge was to build a system where she could communicate and be free to make her own decisions.

– She didn’t want to be institutionalized, so he needed to build a remote system to send the data to the hospital and to be sure she is secure.

– Facilitate the access to care by coordinating different teams (from Social Care and Health) so that she could have “the Hospital at Home.”

In 2009 Jose started an Executive MBA in AESE/IESE and jointly with more 2 colleagues, Simão Calado and Pedro Ferreira, designed Hope Care as their final project based on those 3 key principles. The concept was well received and pushed them to start the company in 2012.

The vision that they implemented in the company was a simple statement: Build a hospital at home without barriers!

In the following interview, Mr. Carvalho shares details about Hope Care’s inception, the various services it provides, its opinion about the industry, and its future plans. Following are the highlights of the interview:

Please brief our audience about Hope Care, its mission, and the key aspects of its stronghold within the HealthTech niche.

When my colleagues and I founded Hope Care, it was clear that the ageing of the population and the growing prevalence of chronic diseases would be the two biggest challenges that Portugal and Europe would face in this century.

The founders’ opinion focused largely on the belief that, as connected care solutions, they could ease the burden of society by allowing more efficient care. We developed a solution that allows people to live independently in their homes for longer and with more quality of life. The goal is to allow access (and this is a fundamental word throughout the process) without barriers to caring through technology.

The pandemic situation has proven our vision: digital solutions, such as Hope Care, are a key technical help to care for people and facilitate access to quality life support.

Read More.

AMC Health: Transforming Care and Enabling Access to Care with RPM 2.0

 

The Centers for Disease Control (“CDC”) estimates six in ten Americans have at least one chronic disease, and four in ten have at least two chronic diseases. These chronic diseases are a significant contributor to premature death and disability, and to the staggering $3.8T annual healthcare costs in the United States. Coupled with current demographic trends of an aging population, it is critical to explore innovative, and efficient care delivery models to meet this market demand.

Virtual care and remote patient monitoring (“RPM”) can be one of, if not the alternative care model that helps transform healthcare delivery maximize patient care treatment effectiveness and provide greater access to care. This shift continues to expand across populations as healthcare organizations work to improve patient care, manage the cost of these chronic illnesses and account for social determinants of health.

Virtual care has become a respite for patients who cannot access in-person care and for those who with chronic conditions. RPM and virtual care help healthcare organizations detect disease decomposition sooner and deliver ongoing chronic condition management. The end result allows for a timelier intervention, increased patient education and empowerment, and improved overall patient-physician relationships.

The COVID-19 pandemic has accelerated telecare and RPM adoption and spurred healthcare organizations to embrace these innovative care delivery models. These tools facilitate meeting consumers at their home and helping them effectively manage their chronic conditions while maintaining good cost and quality outcomes.

RPM is recognized by the Centers for Medicare and Medicaid Services (“CMS”), and reimbursement codes were established in 2019 for the collection and analysis of patient data used to manage chronic and/or acute health illnesses or conditions.

CMS has proposed additional changes to the 2022 Physician Fee Schedule which expands coverage to Remote Therapeutic Monitoring codes and provides an additional option for providers to gain reimbursement in a wide range of patients This expansion demonstrates the growing commitment to the future of RPM/RTM which ensures continued access to care for millions of Americans nationwide.

An RPM program should be a critical component of every healthcare and care management strategy.

AMC’s intelligent telecare management solution utilizes the latest advancements in remote patient monitoring devices and turns data points into actionable analytics; helping both providers and consumers manage their chronic conditions and maintain good cost and quality outcomes.

About AMC Health

Founded in 2002, AMC Health offers a suite of virtual care and RPM solutions that deliver high-quality, low-cost, patient-centered clinical care and timely interventions at a distance. The AMC Health Virtual Care and RPM suite of solutions leverages a superior analytics platform and a simple user interface which integrates easily into clinical workflows.

These solutions provide frictionless consumer experiences as healthcare providers seek to sustain and scale virtual care services beyond the COVID-19 pandemic to address social determinants of health and enable greater access to care and chronic condition management.

AMC Health leverages an advanced data analytics platform with real-time data, the latest in-patient monitoring devices, and a suite of customizable wrap-around virtual care and telecare management solutions.

AMC’s solutions support hundreds of thousands of patients across the healthcare continuum, through our payer, provider, employer group, and government agency partnerships. One of AMC’s partner clients is the Department of Veterans Affair where we deliver telehealth and RPM services to help our veterans manage their chronic conditions more efficiently.

AMC’s FDA Class II cleared clinical decision support platform is combined with end-to-end, clinical and RPM support services that enable healthcare organizations to confidently extend their services beyond the four walls of a hospital and ambulatory clinical setting.

With access to over 200 devices, 70 clinically trained nurses across the US, a dynamic smart-device app, and programs for more multiple chronic conditions and unique diseases, AMC Health is positioned to help organizations succeed with their virtual care strategies.

Read More.